Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma

1. Zhu, A.X.
2. Dayyani, F.
3. Yen, C.-J.
4. Ren, Z.
5. Bai, Y.
6. Meng, Z.
7. Pan, H.
8. Dillon, P.
9. Mhatre, S.K.
10. Gaillard, V.E.
11. Hernandez, S.
12. Kelley, R.K.
13. Sangro, B.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1158/1078-0432.CCR-21-3275 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus